Donepezil (Demenza (10 mg)) is a cholinesterase inhibitor, prescribed for dementia of Alzheimer's disease. It works by increasing the amount of acetylcholine in the brain, which helps in improving ...
BRIDGEWATER, N.J., January 23, 2025--(BUSINESS WIRE)--Amneal Pharmaceuticals, Inc. (Nasdaq: AMRX) ("Amneal" or the "Company") today announced that the U.S. Food and Drug Administration (FDA) has ...
December 17, 2009 — The US Food and Drug Administration (FDA) has approved the first generic versions of donepezil HCl orally disintegrating tablets (generic, Mutual Pharmaceutical; brand name, ...
- Indicated for Treatment of Moderate to Severe Alzheimer's Disease - DUBLIN and EMERYVILLE, Calif., Dec. 24, 2014 /PRNewswire/ -- Actavis plc (NYSE: ACT) and Adamas Pharmaceuticals Inc. (NASDAQ: ADMS ...
Associate Professor, Department of Medicine, Division of Geriatrics, University of California, Los Angeles; Medical Director, UCLA Alzheimer's and Dementia Care Program, Ronald Reagan UCLA Medical ...
Woodcliff Lake, NJ, and New York, July 23, 2010 - Eisai Inc. and Pfizer Inc [NYSE: PFE] announced today that the U.S. Food and Drug Administration (FDA) approved a new once-daily, higher-dose Aricept ...
The withdrawal of donepezil from patients with Alzheimer’s disease (AD) as they reach the moderate-to-severe stages of the disease doubles their risk of being placed in a nursing home within the first ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results